Hyperinsulinemia has been reported to stimulate lipogenesis by activating SREBP, a process that inhibits IRS‐2 (Insulin receptor substrate 2) mediated insulin effects on glucose production (Na et al., 2017). The gene discussed is IRS2; the disease is hyperinsulinism.